Physician profile
Jordan Walker
NPI 1205570561
$759.68
in general payments reported to CMS, 2019-2025
15 companies · $676 in 2025
The $676 reported for 2025 was more than what 88% of General Practice providers received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $83.50 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $759.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $154.15 | 2025 | Entyvio |
| Lilly USA, LLC | $150.26 | 2025 | Omvoh |
| Abbvie INC. | $129.25 | 2025 | |
| Janssen Biotech, INC. | $56.99 | 2025 | Tremfya |
| Madrigal Pharmaceuticals | $45.88 | 2025 | Rezdiffra |
| Celltrion USA INC. | $44.04 | 2025 | Vegzelma |
| Biocryst US Sales Co., LLC | $26.08 | 2024 | Orladeyo |
| Astrazeneca Pharmaceuticals Lp | $23.69 | 2024 | Farxiga |
| Pfizer INC. | $22.48 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $20.84 | 2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $19.54 | 2024 | |
| Phathom Pharmaceuticals, INC. | $19.10 | 2025 | Voquezna |
| Daiichi Sankyo INC. | $17.22 | 2025 | Injectafer |
| Braintree Laboratories, INC. | $15.97 | 2025 | Suflave, Sutab |
| Ardelyx, INC. | $14.19 | 2024 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.